APO-EZETIMIBE
As listed in the register: APO-EZETIMIBE
10 mg · tablet
- Prescription only
- Heart, blood pressure and circulation
- Active substance
- Ezetimibe
- Made by
- Apotex Inc
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
How it works
From the US prescribing label for the same active substance (Ezetimibe). It describes the substance, not this exact product.
Ezetimibe reduces blood cholesterol by inhibiting the absorption of cholesterol by the small intestine.
The molecular target of ezetimibe has been shown to be the sterol transporter, Niemann-Pick C1-Like 1 (NPC1L1), which is involved in the intestinal uptake of cholesterol and phytosterols.
Ezetimibe is primarily metabolized in the small intestine and liver via glucuronide conjugation (a phase II reaction) with subsequent biliary and renal excretion.
Effect of Food Concomitant food administration (high-fat or non-fat meals) had no effect on the extent of absorption of ezetimibe when administered as ezetimibe 10-mg tablets.
Quoted from the prescribing label, sections “Mechanism of Action” and “Pharmacokinetics”. DailyMed · 2026-07-06
Safety of the active substance
From the US prescribing label for the same active substance (Ezetimibe). It describes the substance, not this exact product.
- Ezetimibe tablets are contraindicated in patients with a known hypersensitivity to ezetimibe or any of the excipients in ezetimibe tablets.
- Hypersensitivity reactions including anaphylaxis, angioedema, rash, and urticaria have been reported [see Adverse Reactions (6.2) ].
- When used in combination with a statin, fenofibrate, or other LDL-C lowering therapy, ezetimibe tablets are contraindicated in patients for whom a statin, fenofibrate, or other LDL-C lowering therapy are contraindicated.
- Refer to the Prescribing Information of these products for a list of their contraindications [see Warnings and Precautions (5.1) ].
Quoted from the US prescribing label for the same active substance. Your own pack’s leaflet is the authority for your product. DailyMed
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
United States24 matching products
Spain51 matching products
Netherlands16 matching products
- Ezetrol 10 mg 10 mg · tablet2 makers
- Ezdivule 10 mg omhulde tabletten 10 mg · omhulde tablet
- Ezetimibe Accord 10 mg tabletten 10 mg · tablet
- Ezetimibe Aristo 10 mg tabletten 10 mg · tablet
- Ezetimibe Aurobindo 10 mg 10 mg · tablet
- Ezetimibe Biohorm 10 mg tabletten 10 mg · tablet
- Ezetimibe CF 10 mg 10 mg · tablet
- Ezetimibe Glenmark 10 mg tabletten 10 mg · tablet
SwitzerlandNo exact match for this strength and form
Details
| Made by | Apotex Inc |
|---|---|
| Active substance | Ezetimibe |
| Used in | Heart, blood pressure and circulation |
| Strength | 10 mg |
| Form | tablet |
| Classification | C10AX09 · Heart, blood pressure and circulation |
| Route | oral |
| Dispensing (as stated by the register) | PRESCRIPTION |
| Status | Marketed |
| Marketed | Yes, according to the register |
| DIN | 02427826 |
| DPD drug code | 91232 |
Source: Drug Product Database · 2026-09-30 · not reviewed by a clinician
Contains information licensed under the Open Government Licence – Canada. Reuse terms: Open Government Licence – Canada.
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.